RNTECH and DNAVision announce a co-marketing agreement to offer complete solution for biomarker and target discovery
01-Feb-2006
The RNTECH/DNAVision offer associates these key components, creating a opportunity for pharmaceutical and biotechnology industries to access discovery and development expertise in oncology for biomarker and drugable target discovery and development.
Topics
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.